Added to YB: 2026-04-13
Pitch date: 2026-04-09
HSCS [neutral]
HeartSciences Inc.
-11.56%
current return
Author Info
Canadian Value Investors is a value investing blog looking for ten baggers and focused primarily on small caps. Sign up for the newsletter.
Company Info
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness.
Market Cap
$7.2M
Pitch Price
$2.25
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.01
P/E
-0.56
EV/Sales
880.91
Sector
Health Care Equipment and Supplies
Category
growth
Fishing For Ideas – Investor Summit March 2026 Conference – HeartSciences Inc.
HSCS (overview): Med-tech applying AI to ECGs via MyoVista wavECG (resting 12-lead w/ AI diagnostics) + cloud platform for hosting AI-ECG algorithms. Pre-revenue; recent FDA submission for device. Monetization plan: device placements + SaaS from algorithm usage. Raised capital via Reg A+ & debt conversion. No position.
Read full article (1 min)